Human Platelet Lysate (HPL) is a non-animal derived cell culture growth supplement obtained from blood platelets after freezing and thawing. HPL contains abundant factors and cytokines necessary for cell growth and proliferation. Platelet lysate can be used as a source of growth for replacing bovine serum in cell culture medium. HPL is a rich supplement that maximizes mesenchymal stem cell (MSC) derived from human blood and enhances its genetic stability by removing the risk of xenogeneic immune reactions and viral pathogens. It has been used in numerous phase I clinical trials worldwide. HPL serves as an alternative to Fetal Bovine Serum (FBS) in cell and tissue culture. For example, growth kinetics for primary kidney cells maintained in 5% HPL containing medium were found to be comparable to those of cultures grown in medium supplemented with 10% FBS.  

Human platelet lysaten is derived from human donor platelets and the donor unit is pooled in large batch size, which are then further processed and manufactured to produce a consistent product. Heparin (Porcine), an anticoagulant derived from the porcine intestine, is used in the preparation of human platelet lysate to inhibit coagulation. The USFDA is moving toward adopting European guidelines requiring that bovine materials be removed from culturing media for any therapeutic product containing cultured cells, thus making HPL an attractive alternative to the production and manufacturing processes, which is likely to fuel the demand for human platelet lysate during the forecast period. Replacing bovine serum with HPL allows for expansion and clinical grade production of functional mesenchymal stromal cells by removing the risk of xenogeneic immune reactions and transmission of bovine prion and viral pathogens. There are various methods to prepare human platelet lysate, such as, it can be prepared by repeating freeze and thaw cycles, direct platelet activation by signification, calcium chloride, or detergent. Manufacturers are focusing on pooling as many as 50+ donors for the production of a single human platelet lysate batch with new techniques, offering a window to propel the growth of the HPL market.

The global human platelet lysate market can be segmented on the basis of product type, application, end-user, and geography. Based on product type, the global human platelet lysate market can be divided into human platelet lysate with heparin and heparin-free human platelet lysate. Based on application, the global human platelet lysate market can be classified into research and clinical applications. In terms of end-user, the market can be categorized into biopharmaceutical companies, contract research organizations, academic & research institutes, pharmaceutical companies, and others. Increased application of human platelet lysate in cell culture due to its advantages over fetal bovine serum is anticipated to drive the global human platelet lysate market during the forecast period. Rising acceptance due to less batch-to-batch variability in human platelet lysate is also fueling the growth of the market. Furthermore, increase in opposition for animal blood derived products is indirectly promoting the use of human platelet lysate in cell culture. Fetal bovine serum is the mostly used for cell culture; human platelet lysate is considered potential substitute for fetal bovine serum due to easy availability and less variability in results. These factors are expected to drive the global human platelet lysate market during the forecast period. However, increase in risk of transmission of communicable infectious diseases and the high cost of cell biology research are anticipated to limit the growth of the market during the forecast period.

Geographically, the global human platelet lysate market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America accounts for the leading share of the market, in terms of revenue, followed by Europe. Factors contributing to the dominant position of North America in the human platelet lysate market are high consumption of human platelet lysate for cell culture as a substitute of fetal bovine serum. The  human platelet lysate market in Asia Pacific is expected to expand at a significant CAGR in the near future. High growth rate of the market in the region can be ascribed to increase in research activities and rise in the number of contract research organizations in the region.

Key players operating in the global human platelet lysate market are Mill Creek Life Sciences, LLC, Merck & Co., Inc, STEMCELL Technologies Inc, AventaCell BioMedical, Compass Biomedical, Inc, Macopharma SA, Trinova Biochem GmbH, PL BioScience GmbH, and Cook Regentec, among others.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

With a robust experience in creating exceptional market reports, Transparency Market Research has emerged as one of the trusted market research companies among a large number of stakeholders and CXOs. Every report at Transparency Market Research goes through rigorous research activity in every aspect. The researchers at TMR keep a close watch on the market and extract beneficial growth-boosting points. These points help the stakeholders to strategize their business plans accordingly.

TMR researchers conduct exhaustive qualitative and quantitative research. This research involves taking inputs from the experts in the market, focused attention on recent developments, and others. This method of research makes TMR stand out from other market research firms.

Here's how Transparency Market Research helps the stakeholders and CXOs through the reports:

Inculcation and Evaluation of Strategic Collaborations: The TMR researchers analyze recent strategic activities like mergers, acquisitions, partnerships, collaborations, and joint ventures. All the information is compiled and included in the report.

Perfect Market Size Estimations: The report analyzes the demographics, growth potential, and capability of the market through the forecast period. This factor leads to the estimation of the market size and also provides an outline about how the market will retrieve growth during the assessment period.

Investment Research: The report focuses on the ongoing and upcoming investment opportunities across a particular market. These developments make the stakeholders aware of the current investment scenario across the market.

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.


Human Platelet Lysate Market

Pre Book